Pathology: a key element in UK healthcare

Pathology is a key element of healthcare. As a discipline it represents only around 3% of all healthcare expenditure, but is the basis of over 70% of all patient care decisions. iPP was formed as a joint venture company by Labco and Sodexo to enable the NHS and independent hospitals in the UK to move into a new era of pathology by taking full advantage of new technology and methods that improve the quality and cost efficiency of these critical services.

PathologyDriving forces

Lord Carter’s Independent Review of NHS Pathology and the Department of Health agree that change and consolidation is overdue; and that the NHS could extract significant financial return through the formation of collaborative partnerships with the private sector.

Lord Carter’s review estimates that £500m (from a total spend of £2.5 billion) could be saved on an annual basis through new approaches to the delivery of pathology services.